Publicaciones en colaboración con investigadores/as de Universidad de Sevilla (6)

2023

  1. Radiolabeled Risperidone microSPECT/CT Imaging for Intranasal Implant Studies Development

    Pharmaceutics, Vol. 15, Núm. 3

2020

  1. FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy

    EBioMedicine, Vol. 53

2017

  1. Coordinated downregulation of Spinophilin and the catalytic subunits of PP1, PPP1CA/B/C, contributes to a worse prognosis in lung cancer

    Oncotarget, Vol. 8, Núm. 62, pp. 105196-105210

2016

  1. Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression

    Oncogene, Vol. 35, Núm. 36, pp. 4719-4729

2015

  1. Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer

    PLoS ONE, Vol. 10, Núm. 3

2014

  1. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1

    Cancer Discovery, Vol. 4, Núm. 3, pp. 293-303